Zebrafish as a Successful Animal Model for Screening Toxicity of Medicinal Plants

1Herbal plants have pharmacological and therapeutic characteristics due to the natural chemical compounds they contain. Hence, they are widely utilized every day for culinary purposes and nutritional supplements to promote health. This product can be toxic, so its toxicity must be measured to ensure adequate safety for human health. Although many people view most medicinal plants as safe, poisoning can occur in some cases. Consumers can also be exposed to potential health risks caused by specific components or contaminants of botanical products; thus, their risk needs to be evaluated. Plant materials and their extracts contain various toxic substances synthesized by plants as a defense against disease, insects, and other organisms. Botanical toxicity studies are complicated due to expense, time, use of animals, and the complex mix of components. The most commonly used extraction solvents, from polar to non-polar, are water, ethanol, methanol, acetone, ethyl acetate, chloroform, dichloromethane and hexane, and numerous researchers have studied the effectiveness of these solvents. Various extracts may display distinctive cytotoxicity traits and a wide variety of pharmacological consequences at different concentrations. Additionally, numerous factors affect compounds, such as the type and volume of extraction solvents used and varying storage environments. Bioactive compounds in medicinal plants can have toxic impacts on cardiac glycosides, phorbol esters, alkaloids, cyanogenic glycosides, and lectins. The statistical evaluation carried out by the National Pharmaceutical Control Bureau and Health ministry’s Malaysian Adverse Drug Reaction Advisory Committee in 2013 confirmed that 11,437 cases of harmful drug reaction had been reported, and 0.2% were due to herbal remedies. Thus, the evaluation of the toxicity of potential drug compounds has been enhanced in recent years. Allopathy drugs and complementary and alternative medicines require a toxicology assay to identify any harmful effects that are not well-known until signs and symptoms appear after high consumption.

2However, the main objective of toxicity research is to predict human toxicity via fast and accurate testing of many substances based on model systems, and different routes of drug delivery systems such as using nanoparticles in the gastrointestinal tract or chemical fertilizers and water retention as an example. Previously, classical toxicity screening (including rodents, dogs, and rabbits) involved the compilation of data from a given laboratory for one substance at a time; however, these tests are frequently expensive, time-consuming, and tedious. This classic method focused on studying chemical compounds on phenotypic cell or animal results. Thus, an attractive alternative approach involves applying the 3R concept of human-animal studies (i.e., reduction, replacement, and refinement), but it is not consistent with the use of rodent animal models. Replacement: Zebrafish assays can be used to substitute such animal-toxicity studies using larval zebrafish, and it can be shown that larval zebrafish represent a critical system model; Reduction: zebrafish larvae can be used as a first-level model for toxicity to classify toxic drug candidates so that more stable drugs can be evaluated in mammalian models; Refinement: The model of embryonic and larval zebrafish provides a refined design to research organisms since embryos are partially fertilized and translucent in their early life. It is recommended that the number of animals is limited, the test methods minimize pain and suffering of experimental animals, and approved substituted animal tests are used as much as possible.

3The zebrafish (Danio rerio) is a suitable model for screening drugs for potential use to treat human diseases based on phylogenetic analysis of fish and human genomes, which shows similar morphology and physiology of the nervous, cardiovascular, and digestive systems. The zebrafish genome has been sequenced in full. Zebrafish are a fast model for the study of genetic and de novo mutations. The genes can inactivate in vivo, simulate human phenotypes, and obtain information on human diseases with genetic background through genomic editing approaches, such as CRISPR/Cas9 or artificial site-specific nucleases, zinc-finger nucleases, and transcription activator-like nucleases. Zebrafish also provide a significant data file for vertebrate animals that enables researchers to anchor biochemical, genetic, and cellular hypotheses to high-performance observations at structural, functional, and behavioral levels. The zebrafish embryotoxicity test, or fish embryotoxicity test (FET), is gaining popularity because it provides a total and well-defined developmental duration for a vertebrate embryo and allows the study of its early life stages. As experimental models, both adults and zebrafish embryos are used. For example, various compound tests (e.g., measurement of drug cardiotoxicity) have been conducted to assess drug effects in zebrafish efficiently. Additionally, for the last two decades, zebrafish have been used to study angiogenesis, metastasis, anticancer drug screening, and an assessment of drug toxicity. In summary, the cell structural and biochemical similarities between humans and zebrafish enable rapid forecasting of the possible impacts of chemical and other substances on human communities. Because zebrafish are becoming increasingly important as a test model, husbandry requirements to enhance the reproducibility and efficiency of this type of model in research environments are needed.

4Toxicity studies generally begin in in vitro studies, with many different cell lines at different sample concentrations. The substance is then tested in several animal models, especially in mice and rats, before using on patients. As mentioned in Table 1, there are several explanations why zebrafish as an animal model could be extremely useful for intermediate toxicity tests.

5In vitro toxicity studies are inexpensive, fast, and easy, as shown in Table 1, but cultured cells are poorly associated with in vivo processes and therefore have limited translation benefit, while accurate data are obtained from laboratory rodent studies to extrapolate toxicants to humans. Hence, the gold standard for predictive analysis of chemical risks to humans remains vertebrate toxicity studies; however, these studies are unsuitable for initial toxicity screening due to the reasons above and often involve significant amounts of a valuable test compound. There has been a trend in the last 30 years towards the restricted use of higher animals in herbal toxicology studies in particular. These animals have a series of restrictions. For example, rodents may be immune to the cardiotoxicity, especially when the endpoint is left ventricular contractile function. This may be due to rodents’ ability to substitute for myocyte failure by employing alternative mechanisms. The zebrafish model is especially useful for the bioassay-guided identification of bioactive secondary metabolites. The National Health Institute (NIH), USA, recently promoted a zebrafish model organism to study various genetically engineered diseases. The Food and Drug Administration has recognized zebrafish tests for toxicity and safety evaluations for investigative newly developing drugs. Large volume screening platforms exist in the form of a multi-wave plate format for testing chemical impacts on embryo development by assessing deformities, mortality, and structural characteristics across a range of concentrations. Small molecules may be introduced directly into the water in multi-well racks, where fish take them up via diffusion. The researched drugs can also be injected into the yolk sac. Thus, the zebrafish is a great model for studying the premature embryonic diet on toxicants. Although researchers hope that both adults and embryos will prove useful for toxicology studies, embryos are ideal for toxicity examinations because of the transparency of the egg, which makes it easy to detect developmental phases and evaluate endpoints during the toxicity test. This enables technical and economic benefits over rodent models to reduce the number of substances and reduce the cost of animals in the development of drugs. Up to 200–300 embryos can be developed per pair of adult zebrafish, while a typical pair of rodents only produce 5–10 descendants per matching occurrence. Five days after post fertilization (dpf), the heart, liver, brain, pancreas, and other organs are created. The three-lobe liver of zebrafish reflects humans’ biological function, including the absorption and production of lipids, vitamins, proteins, and carbohydrates. One of the significant benefits of using zebrafish is that compounds can be easily supplied by adding water, similar to chemicals in the cell culture medium, which generally requires an overall amount of only 100 μL during growth. Their optical clarity makes it easy to produce and recognize phenotypic properties during mutagenesis screening, and determine toxicity endpoints during toxicological analysis. In addition, zebrafish embryos have been incredibly helpful in studying heart development and the functional effects of toxicants. Figure 1 illustrates the temporal distinction between humans, rats, and zebrafish in early developmental life. During development, there are still several limitations in the chemical identification of zebrafish. The fish is ectothermic and lacks heart septa, limbs, synovial joints, cancellous bones, lungs, and other organs. Age is one of the most important limitations. Although chemical tests can be undertaken in adult fish, a high-performance scan using appropriate quantities of small molecules requires the animals to fit into a multi-well plate. The analysis of gene expression throughout the larvae is feasible due to the optical transparency of the zebrafish tissues, which enables good penetration for light microscopy.

6An alternative preliminary toxicity test is called the brine shrimp lethality test, which involves testing different toxicant concentrations. However, this technique does not reveal abnormalities or causes of death. In contrast, using zebrafish as a screening model animal has some rational benefits, including large embryos, large numbers of embryos for testing, and simple visualization of organogenesis using fluorescence and transgenic strains. Additionally, the ability to view biological processes provides the researcher with visual links to the organ system dynamics and, possibly, interorgan systems.

7Today, many herbal products claim to provide pharmaceutical health benefits but do not provide any toxicological data; thus, the safety of these drugs is questionable. This review aimed to compare the results of studies of the toxicity of medicinal plants and assess the toxicity tests used to analyze some of these commercial products from plants. This paper is the first review to assess the toxic and teratogenic effects of plant extracts on the zebrafish model to the best of our knowledge.

8One of the main goals of medicinal plant toxicology research is to identify many bioactive compounds with specific toxicity within a short period. For many years, higher species have been used as models to measure medicinal products based on their toxicity. For instance, recent studies of acute toxicity have mainly used mice as the animal model. Nevertheless, it is difficult to achieve a thorough and immediate toxicity check with this organism because of its strong state of breeding, high expenses, complicated procedures, and ethical restrictions. Instead of using rodents, fish are the best candidate for this purpose. Fish traditionally have been used in toxicity testing of individual substances and effluents, and today zebrafish are commonly utilized to test for developmental toxicity, general toxicity and to carry out medication screening as a credible vertebrate model. Hence, the first large-scale studies for bioactive molecules using zebrafish embryos were published, using the merits of zebrafish as phenotypic testing models to evaluate the effects of biomolecules and explore different bioactive compounds. The zebrafish is widely used in numerous subfields of biology, and without a doubt, it is one of the leading species in various research areas, including developmental biology, ecotoxicology, and genetics. Zebrafish embryos can also quickly consume tiny molecular compounds, thus providing a valuable model for drug testing and evaluating teratogenic effects of exposure to toxic compounds. Zebrafish embryos and larvae are outstanding models for testing the toxicity of substances, especially if those substances are present in low quantities. Zebrafish larvae are very useful in imaging studies, and they likely will prove useful for non-imaging endpoints. Scientists are discovering new innovative paths for evaluating biochemical processes. Within 5–6 days dpf, zebrafish development reflects the full developmental period of a vertebrate embryo before it becomes self-sustainable and, therefore, this substitute organism is not currently recognized as a genuine in vivo form by European law.

9Teratology is the study of unusual growth, and a teratogen is any substance that triggers the production of a congenital anomaly or enhances the occurrence of a specific hereditary deficiency. Screening for teratogenicity includes introducing zebrafish embryos to the required concentration of the compound of interest, and it has become a popular model for analyzing the teratogenic effects of medicines. Teratological and embryo-toxic effects are easy to detect due to the transparency of zebrafish embryos during their growth outside of their parent. Teratogenic effects include tail malformation, pericardial edema, malformation of the notochord, scoliosis, yolk edema, and growth delays. Therefore, it is essential to evaluate the embryotoxic and teratogenic toxicity of medicinal plants on embryo growth. Embryo malformations may be caused by activation of the Caspase-3 enzyme, which is the leading cause of apoptosis, or by other factors such as reactive oxygen species-induced oxidative stress.

10The effectiveness of the zebrafish model system was evident in the 1960s and 1970s, as numerous studies used zebrafish as bioassays of chemicals affecting normal functioning and reproductive success. During the 1980s and 1990s, many researchers verified that zebrafish are a convenient and reliable option for comprehensive toxicological screening and early life and lifetime exposure tests. In 2000, the first chemical screening procedure was reported that allowed researchers to test a very slight concentration of compounds on live zebrafish in 96-well plates. To date, there are ten types of tests used to study toxicity in zebrafish: (1) the zebrafish embryo toxicity test (FET); carcinogenicity; (2) developmental toxicity and teratogenicity assessments; (3) reproductive toxicity assessment; (4) behavioral toxicity assessment; (5) endocrine disorders; (6) acute toxicity; (7) neurotoxicity; (8) optical (ocular toxicity); (9) cardiotoxicity; and (10) vascular toxicity. Among the available tests, FET is the most useful for assessing chemical and substance toxicity in zebrafish. Numerous toxicity studies of specific chemicals have shown a significant correlation between results for zebrafish embryos and acute toxicity of fish. The FET test aims to determine the acute toxicity of the embryonic phases and establish variables for zebrafish. It is based on mortality and teratogenesis of the zebrafish embryos. FET is a valuable option for replacing the use of adult animals to evaluate toxicity and enhance existing toxicity assays. Advantages of this test include:A wide range of chemicals may be relevant;Embryos are short-lived, susceptible, cost-effective, and have low variability;The regulatory and scientific communities consider them to be standardized;The tolerance of various species or organisms can be compared.

11A wide range of chemicals may be relevant;

12Embryos are short-lived, susceptible, cost-effective, and have low variability;

13The regulatory and scientific communities consider them to be standardized;

14The tolerance of various species or organisms can be compared.

15The possibility of tracking many toxicity endpoints, including alteration of molecular processes and malformations, is one of FET’s main advantages with Danio rerio. With the FET test, acute toxicity is assessed based on positive results, and embryo formation is examined every day for any unusual developmental phenotypes, especially morphological defects, including (i) coagulation of fertilized eggs; (ii) lack of somite formation; (iii) lack of detachment of the tail-bud from the yolk sac; and (iv) lack of a heartbeat. Nagel (2002) outlined these toxicity indicators as measured using an inverse light microscope based on “yes” or “no” responses to the presence of the four factors. On the other hand, Hermsen et al. introduced a new model of embryotoxicity (ZET) using the general morphology score (GMS). A separate scoring list was established for teratogenic impact, which helped track slow progress, developmental delay, and teratogenicity. However, the ZET, along with GMS, operates as an essential and useful test method for screening the chemicals’ embryotoxic properties in the compound groups studied. Furthermore, the MolDarT was created with zebrafish eggs/larvae to develop a molecular mechanism test method. It is based in theory on the DarT (Danio rerio teratogenicity test), established by Nagel et al., which reveals and tracks the developmental impact and deformities of freshly fertilized zebrafish eggs within 48 h.

16Experiments to test toxicity include acute, sub-chronic, and chronic studies of compounds’ toxicity to specific organ pathways and hypothesis-driven research. Zebrafish were found to be a useful tool for the comprehension not only of neurotoxicants’ structural and chemical effects but also for the assessment of behavioral dysfunction correlated with such toxicity. Several behavioral endpoints are used in neurotoxicity studies to determine the therapeutic influences of medications and their neurotoxins on neuron development in zebrafish. There is an incomparable system to identify endocrine activity lacking significant morphological abnormalities. For the reasons described above, zebrafish toxicity screening provides many significant experimental advantages, including embryo and larvae visibility, high-efficiency short test time, low number of necessary compounds, ease of handling, and direct delivery compounds. The zebrafish embryo develops quickly outside the mother’s body and enters maturity in a couple of months, among other benefits. Additionally, more than 70% of the disease-associated genes are similar to those found in human diseases. Furthermore, the physical, biochemical, genetic, and molecular makeup of zebrafish, including organs and tissues, has been demonstrated to be identical to their mammalian relatives. Metabolites, signaling mechanisms, and neurological and cognitive structures are similar to those in mammals.

17A compound’s toxicity is measured using two indicators: the median effective concentration (EC50) and the median lethal concentration (LC50). The concentration-response curve is generated using 24 h of data to obtain the EC50 (teratogenic effects) and LC50 (embryotoxic effects). The ratio of LC50 to EC50 is the corresponding therapeutic index (TI). In pharmaceutical administration, a TI value < 1 is optimal. The strength of the association between zebrafish embryo LC50 values and rodent LD50 values for 60 different compounds was demonstrated in one particular laboratory study by Ali and colleagues. Test protocols for the use of zebrafish embryos (FET) in the Organization for Economic Cooperation and Development (OECD) test guideline 236 were tested and applied. As determined by OECD guidelines, the value of LC50 is calculated based on lethality, coagulation, lack of somite formation, heartbeat failure, and a lack of detachment of the tail. In contrast, teratogenic effects are used to compute the EC50 values. Parng et al. (2002) showed that the toxicity of the drug tested (ethanol) was similar for zebrafish and mammals with log LC50 values of 4.0 and 3.8 mg/mL, respectively. Throughout the screening steps, zebrafish bioassays have been used to classify the active fractions based on endpoints developed and tested in other species, which led to identification of the actual effect of extracts on different life stages in zebrafish (Table 2).

18Additionally, indicators such as delayed growth, restricted movement, irregular head-trunk angle, scoliosis/flexure, and yolk sac edema have been analyzed in developing zebrafish. However, recent findings indicate that herbal products’ metabolism using zebrafish can represent actual outcomes of mammalian methods, while single in vitro methods cannot do so. Table 3 lists some toxicity screening studies of medicinal plants that used zebrafish as the model organism.

19Previously, zebrafish were used for toxicity evaluations of agrochemicals, but recently they have been used for toxicity assessments for therapeutic compounds. Of note, the zebrafish response is also a sensitive predictor of irregular toxicity changes. In particular, specific tasks have been created or changed to test the behavior of zebrafish compared to rodent models. Quite basic swimming steps and the ability to capture/consume can often be helpful. The creation of behavioral tests that can employ repeated tests in a short window (i.e., within 24 h) may prove to be the perfect compromise, and some researchers have begun designing tasks that use multiple tests to measure their acquisition during a single session. If one particular mode of action is to be detected, various experimental parameters can contribute to incoherent actions (hypo-or hyperactivity) responses of zebrafish when determining toxicity. As a consequence, several behavioral evaluation methods have been developed to address different behavioral endpoints, including spontaneous tail coiling, photomotor response (PMR), locomotor response (LMR), and the alternating light/dark-induced locomotor response (LMR-L/D), which we will not discuss further in this review.

20Zebrafish are easy to control in toxicology screening tests using different platforms (exposure format) for detecting parameters. The type of exposure format is classified into ten categories, six of which are useful. Zebrafish body length at 5 dpf is about 4 mm, so a multiple-well plate can be used to incubate zebrafish larvae. However, embryos cover a wide range of sizes based on the performing test, so 6-well to 96-well transparent plates can be used. Analytical experiments that use microplates, such as cell-based evaluation, can be conducted and applied to high-performance primary drug screening. Furthermore, zebrafish larvae fit onto 96 or 386-well microplates. Because the zebrafish embryo is tiny, can be handled easily, and requires only a small number of compounds per test, they can be screened in a 96-well microplate format. However, OECD TG236 suggests using a 24-well plate (with a medium of 2 mL per well), as it overcomes the problem of high concentration developing in conjunction with evaporation. Nevertheless, TG236 specifically checks for lethality and only considers developmental defects indirectly. Table 4 lists several studies that analyzed embryotoxicity and apoptotic induction.

21Apoptotic functions are identical in zebrafish and humans, and can be easily detected using fluorescent labeling methods. The zebrafish model was used to discover the toxicity of 69 plants in this review, including 88 crude plant extracts, eight polyherbal formulates/commercial products, and two phytocompounds. In terms of exposure format, out of 58 studies described in Table 4, 25 used 24-well plates, and 10 used 96-well plates.

22It seems that the number of zebrafish screening tests to evaluate the toxicity of compounds will keep increasing each year. The use of fish embryos was proposed as an alternative screening method to assess fish’s acute toxicity. In transparent species, the effects of compounds on different organs, such as the brain, heart, cartilage, liver, intestine, and kidney, were identified without arduous screening. This specific trait also makes it feasible to quickly measure toxicity endpoints of multiple substances, highlighting the efficacy of toxicity models using zebrafish embryos. For example, after 2005, regular sewage surveillance monitoring of fish embryotoxicity has been made compulsory, substituting conventional fish tests no longer approved for standard whole effluent assessment.

23From the egg phase, zebrafish embryos can survive by ingesting yolk and can visibly be tested for malformation for a few days in a single well of a microplate. When the embryo is not clumped, has a cardiac beat, has fully shaped body sections, and the tail is detached from the yolk, the standard endpoints of embryogenesis have been said to have occurred. The main characteristics of embryogenesis and the genetic basis of growth in zebrafish have been widely researched. Another significant indicator for assessing toxicity is the hatching rate, and zebrafish embryos start to hatch at about 48 h post-fertilization (hpf) under ordinary conditions. Delayed growth of zebrafish embryos can result in a low hatchability and can thus be among the critical aspects of the sub-lethal effects of plant extracts.

24The essential cell structure and biochemical similarities between humans and animals enable researchers to use the zebrafish model to forecast the possible impacts of chemicals and other human communities. Furthermore, it is easier to study the biochemical mechanisms of significant zebrafish organs, whereas histological analysis required in the mouse model is more difficult. Testing parameters commonly used for zebrafish include embryo survival rate, lethality, behavior, and organ deformity; researchers have found that zebrafish exhibit a strong dose reaction to toxicity, making it a useful animal model for toxicity screening. Previously, we mentioned FET; most studies use OECD guidelines to measure toxicity of crude extract/fractions, and those guidelines for FET set levels as follows: dangerous (10 mg/L < LC50 < 100 mg/L), toxic (1 mg/L < LC50 < 10 mg/L), and carcinogenic (LC50 < 1 mg/L).

25Zebrafish developmental toxicity testing is a type of FET (FET can be used for any fish species), and it is primarily aimed at supplementing developmental toxicity screening in mammals. When detecting developmental toxicity in zebrafish embryos, endpoint parameters are categorized in two ways compared to a standard (negative control). First, lethality is assessed based on coagulation, malformation of somites, absence of heartbeat, and lack of tail detachment. Second, teratogenicity is evaluated based on abnormal eye development, lack of spontaneous movement, unusual heart rate, lack of pigmentation, and edema. The standard shows normal development.

26In developmental toxicity studies, the mortality of zebrafish embryos occurs before 24 hpf or just after hatching, and cardiac deformities are sometimes detected, such as pericardial edema, abnormal heart form due to edema or aplasia, and irregular heartbeat. The motility of the zebrafish embryo can also be affected by toxins, as exhibited by coagulation, heart failure, and non-development of the yolk embryo’s tail. Other factors, such as reactive oxygen species-induced oxidative stress, are also assumed to be linked to abnormal development during embryogenesis. A teratogenicity test is carried out to assess developmental toxicity (i.e., if the compound has teratogenic effects on the embryos). After treatment, the development stages of embryos are observed under an inverted microscope to look for malformations based on the numerical system designed from 5 to 0.5, where 1 indicates severe malformation, 4 indicates slight malformation and 5 is totally normal. The teratogenic score is calculated as follows:

27In such analyses, it is essential to specify the observational setup and endpoint evaluation (i.e., which particular behavioral change(s) will be analyzed). Below we discuss the defects to vital organs of zebrafish that can occur during the toxicity assay.

28The zebrafish is an excellent model organism for studying organogenesis and the cardiovascular system; thus, it was developed quickly as a cardiovascular research model organism. The first active organ that develops in zebrafish is the heart. The heartbeat is a primary and relevant sub-lethal endpoint in the embryonic fish toxicology assay. It is regularly assessed as an indicator of toxicity in zebrafish embryos and estimates fish metabolic function as a biological factor. In zebrafish, the normal embryonic heartbeat of 120–180 beats per minute is close to that of the human heartbeat. At the embryo pharyngula level, the heartbeat pulse can be tracked because the tail is visibly pigmented. Ismail et al. reported that the most vulnerable stage for external stimulation (e.g., chemicals, toxicants, and physical pressure) is the early growth stage of embryos. In toxic environments, pericardial edema can be caused by the general response. Pericardial edema in zebrafish embryos can be caused by many different toxicants, and changes in heartbeat rate may be a common reaction to toxicant exposure. The toxicity mechanism of a compound is due to activation of Na+ and K+ inhibitors, and these Na+ channels likely trigger the heart rate. An elevated heart rate can overwhelm the myocardium and cause operational and biological damage to the heart of zebrafish. For example, studies of the effects of medicinal plants such as Andrographis paniculata, Cinnamon zeylanicum, Curcuma xanthorrhiza, Eugenia polyantha, Orthosiphon stamineus, Tinospora cordifolia, Carthamus tinctorius, and Euodia retaecara on zebrafish embryos reported a decreased heartbeat. In contrast, embryos treated with curcumin showed a heartbeat increase.

29The heart is anteroventral in zebrafish and lies between the operculum and pectoral girdle in the thoracic cavity. It is divided into the atrium, sinus venous, ventricle, and bulbous arteriosus, it starts beating at about 22 to 26 hpf, and produces a full set of ion channels and metabolic regulation. In later stages, the normal function of the heart plays a leading role in the growth of the embryo. An abnormally formed cardiovascular system can result in the unusual overall growth of the animal, severe malformations, and a malfunctioning body. Additionally, when the heart is swollen due to the active compounds in the pericardial sac, cardiac cells become irritated. The following method is used to measure a normalized cardiac rate:

30Zebrafish embryos are also being used in cardiotoxicity (reduction of heartbeat) studies to model various human diseases. The morbidity and mortality of people with cancer are associated with cardiotoxicity. Most common drugs have cardiotoxic effects and affect the heart in zebrafish model systems. A very accurate zebrafish cardiotoxicity assay assessing potential drug toxicity to the human cardiovascular system has been documented. Thus, the effects of cardiotoxicity, such as minimal or no blood flow, may be explained by the fact that a large percentage of apoptotic heart cells lead to underdevelopment of the heart and pericardium, which in turn can cause an unusual heartbeat and a delay in body development (growth retardation). Gao et al. reported that the expression of two heart markers (amhc and vmhc) reflected the seriousness of heart failure in zebrafish.

31At day 3 of the formation of zebrafish embryos, the primary and sprout vessels become active, and the blood vessel structure is quite like that in the human body. A single endothelial cell layer surrounded by supporting cells forms the vessels that constitute the circulatory system. Endothelial precursor cells result from vasculogenesis and angiogenesis within the lateral mesoderm of mammal embryos. Vasculogenesis explains the de novo establishment of blood vessels by angioblast coalescence. In comparison, angiogenesis includes the creation of new vessels by earlier developed vessels and is typically described by the sprouting of an endothelial cell. Kinna et al. reported the potential role of zebrafish crim1 in regulating vascular and somatic development.

32Gills are essential to fish because they are the leading site for gas exchange, and they engage in osmoregulation, ionic control, acid-base balance, and excretion of nitrogen waste in fish. Several studies on the histological organization and physiology of gills in many fishes have been carried out. Enhanced green fluorescent protein (EFGP) is a successful marker for toxic chemicals in transgenic zebrafish. One of the benefits of this zebrafish transgenic model system is that spatio-temporal patterns of EGFP expression can be assessed during initial stages after exposure to a particular toxicant. A study by Seok and colleagues found that the most effective and earliest expression of EGFP was seen in zebrafish gills, indicating that the gill is the most sensitive tissue and is impacted at relatively low metal concentrations. The studies conducted by Rajini et al. showed that visible damage such as inflammatory cell infiltration in gills, minimum aggregation in primary lamellas, secondary lamellae fusion, diffuse epithelial hyperplasia, and multifocal cell mucosal hyperplasia occurred in zebrafish exposed to sublethal concentrations of a combination of pesticides. Generally, in zebrafish, gills exposed to toxicants from 48 to 72 h show fusion, and clubbing of distal lamellar regions. However, for herbal toxicity, this organ has not fully been considered.

33One of the endpoints of embryonic growth in zebrafish is when the tail is detached entirely from the yolk, which can be affected by toxicants. The tail emerges during the larval stages from the primordium in the ventral fin fold, which coincides with a gap in the melanophore line immediately before the back tip of the notochord. Tail kink and tail bending are malformations caused by toxicity. However, tail malformations and spinal axis disabilities can also be affected by predation and a drastic decrease in the food supply.

34Like human embryos, zebrafish embryos possess a protruding yolk sac, but in zebrafish, it serves as a nutritional reservoir for the embryo. Yolk sac edema is a common pathology in toxicity tests of zebrafish, and it is a sign of reduced nutrient adsorption by the embryo. It may be affected by overhydration of osmoregulation and toxin accumulation in the yolk sac. Malformation in other organ systems that help allocate nutrients may be the trigger for this deficiency. This deficit could also contribute to nutritional absorption, undernourished embryos, and embryo mortality. After maternal exposure, toxicants can be placed in the yolk sac as well. As they are deposited in the yolk, the embryo becomes directly exposed to these toxicants, which allows for definitive exposure timing. Hence, a finite quantity of maternally stored embryo yolk is used in the zebrafish embryo for early feeding, and it provides an understanding of embryo nutrition processes and disruptions that occur due to toxicity exposure.

35In zebrafish developmental toxicology research, there are numerous classes of yolk phenotypes. Yolk sac edema is quite like yolk edema. Yolk retention refers to decreased mobility/use or malabsorption of the yolk. If the area of the yolk sac is significantly greater in a test fish than in the control fish, it suggests that yolk absorption has been affected. On the other hand, the rapid use of yolk leads to a smaller yolk area and indicates enhanced movement or use of the yolk.

36A zebrafish embryo is assumed to have been hatched once it is entirely out of the chorion. Certain drugs and extracts can affect hatchability. Lack of hatchability may imply a growth lag or slow development. For example, zebrafish embryos exposed to Millettia pachycarpa extract exhibited a considerable dose-dependent reduction in embryo hatching. Zebrafish embryos start to hatch at 48 hpf in ordinary conditions, but percent hatchability after 72 h post-treatment exposure (hpte) is calculated using the following formula:

37According to the literature, this model to determine the toxicity of crude extracts or bioactive compounds, and toxicological effects can be compared.

38Changes in fish behavior are sensitive indicators of unintended chemical pollution. The zebrafish model is vital in evaluating the effects on embryonic/larval activity of developmental exposure to harmful compounds. Comprehension and monitoring of these considerations and future revision/harmonization of procedures will reduce the uncertainty of the outcomes for chemical hazard assessments.

39Several early life researches have been carried on the effects of salinity on zebrafish. When larval zebrafish are subjected to mild environmental stressors, severe salinity shifts lead to a quick locomotive reaction. Lee and colleagues showed that larvae (5 dpf) treated with NaCl exhibit dramatically increased locomotive activity and concentration-dependent reactions. A linear relationship between whole-body cortisol and sodium chloride in the concentration range of 5.84 ppt was shown in zebrafish larvae.

40Yumnamcha et al. reported the presence of saponins, alkaloids, phenolic compounds, and triterpenoids in the aqueous extract of Millettia pachycarpa. Potent hemolytic activity was found to lead to acute cell membrane death in zebrafish. The toxic function of saponin in the zebrafish embryo is uncertain. However, prior studies have shown that it can be caused by physicochemical characteristics (surfactant) and/or membranolytic impacts on the chorion, a semipermeable membrane that covers the embryo until it hatches. Moreover, according to Liu et al. and Yumnamcha et al., some bioactive compounds such as saponin mixtures and alkaloids can cause damage to DNA. Artemisia capillaris was evaluated for its toxicity based on embryotoxicity, and isofraxidine 7-O-(6′-O-p-coumaroyl)-β-glucopyranoside was isolated from this plant. The toxicity, death, and cardiac rates of handled zebrafish embryos are used to diagnose safe and effective concentrations.

41In contrast to flavone, artificial flavonoids such as kaempherol, 7-hydroxyflavone, 6-methoxyflavon, and 7-methoxyflanone induced considerable toxicity in zebrafish larvae. Additionally, the lack of flavonoids can potentially trigger oxidative stress to cellular molecules, which leads to lower survival rates of zebrafish embryos. Bugel et al. reported that 15 of 24 flavonoids affected at least one or more behavioral and developmental endpoints in zebrafish. However, they focused on two endpoints in their experiment: abnormal spastic behaviors (72 hpf) and alternations in the larval photomotor responses assay (120 hpf). Li et al. exposed zebrafish to Xiaoping at high doses, and many larvae opted to swim at a medium to a low rate, which led to decreased locomotion ability. Changes in larval behavior have been confirmed to be associated with damage to the central nervous system. The function of neural population numbers in animals with a broader central nervous system is being measured using fluorescence and new devices developed over the last decade. In one study, zebrafish embryos subjected to different caffeine dosages demonstrated a decrease in susceptibility to touch-induced movement. Such abnormalities were linked to changes in muscle fibers and axon projections of both primary and secondary motor neurons through immunohistochemistry. Furthermore, toxicological testing may also impact other environmental variables (temperature, water, pH, total hardness or dissolved oxygen).

42The data collected in this study suggest that zebrafish embryotoxicity tests are able to evaluate drug toxicity and that the zebrafish model offers a suitable replacement for laboratory animals such as rats, mice, and rabbits. As a toxicology model, zebrafish can expose developmental toxicity mechanisms because they are close to mammals. Zebrafish embryos and larvae showed significantly higher susceptibility to toxins than did adult zebrafish. In this review, most of the extracts were polar, such as ethanol, methanol and aqueous extracts, which were used to detect the toxicity and bioactivity. However, the use of the zebrafish model will provide insight into the mechanisms of toxicity of medicinal plants and will help identify and discover new medications for the treatment of human diseases. The zebrafish model is planned as a replacement for models based on higher vertebrate animals to study medicinal plants’ toxicity.